Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 21856169)

1.

Challenges and opportunities in targeting the costimulation pathway in solid organ transplantation.

Wojciechowski D, Vincenti F.

Semin Immunol. 2011 Jun;23(3):157-64. doi: 10.1016/j.smim.2011.07.002. Epub 2011 Aug 19. Review.

PMID:
21856169
2.

Developing therapeutic 'arrows' with the precision of William Tell: the time has come for targeted therapies in kidney disease.

Mundel P, Greka A.

Curr Opin Nephrol Hypertens. 2015 Jul;24(4):388-92. doi: 10.1097/MNH.0000000000000137.

PMID:
26050127
3.

Belatacept in kidney transplantation.

Satyananda V, Shapiro R.

Curr Opin Organ Transplant. 2014 Dec;19(6):573-7. doi: 10.1097/MOT.0000000000000134. Review.

PMID:
25333833
4.

High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept.

Krummey SM, Cheeseman JA, Conger JA, Jang PS, Mehta AK, Kirk AD, Larsen CP, Ford ML.

Am J Transplant. 2014 Mar;14(3):607-14.

5.

Co-stimulatory blockade with belatacept in kidney transplantation.

Chopra B, Sureshkumar KK.

Expert Opin Biol Ther. 2014 May;14(5):563-7. doi: 10.1517/14712598.2014.896332. Epub 2014 Mar 12. Review.

PMID:
24620724
6.

The emerging role of TH17 cells in organ transplantation.

Sullivan JA, Adams AB, Burlingham WJ.

Transplantation. 2014 Mar 15;97(5):483-9. doi: 10.1097/TP.0000000000000000. Review.

PMID:
24212502
7.

Costimulatory pathways in kidney transplantation: pathogenetic role, clinical significance and new therapeutic opportunities.

Esposito P, Grosjean F, Rampino T, Libetta C, Gregorini M, Fasoli G, Marchi G, Sileno G, Montagna F, Dal Canton A.

Int Rev Immunol. 2014 May-Jun;33(3):212-33. doi: 10.3109/08830185.2013.829470. Epub 2013 Oct 15. Review.

PMID:
24127878
8.

T-cell co-stimulatory blockade in transplantation: two steps forward one step back!

Riella LV, Sayegh MH.

Expert Opin Biol Ther. 2013 Nov;13(11):1557-68. doi: 10.1517/14712598.2013.845661. Epub 2013 Oct 1. Review.

PMID:
24083381
9.

Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma.

van Gelder T, Baan C, Vincenti F, Mannon RB.

Transpl Int. 2013 Sep;26(9):938-48. doi: 10.1111/tri.12140. Epub 2013 Jul 4.

PMID:
23822608
10.

Cylex ImmuKnow Cell Function Assay.

Zeevi A, Lunz J.

Methods Mol Biol. 2013;1034:343-51. doi: 10.1007/978-1-62703-493-7_21.

PMID:
23775749
11.

Immune suppression in cynomolgus monkeys by XPro9523: an improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRn.

Bernett MJ, Chu SY, Leung I, Moore GL, Lee SH, Pong E, Chen H, Phung S, Muchhal US, Horton HM, Lazar GA, Desjarlais JR, Szymkowski DE.

MAbs. 2013 May-Jun;5(3):384-96. doi: 10.4161/mabs.23976. Epub 2013 Apr 2.

12.

Transplantation: The promise of co-stimulatory blockade in transplantation.

Barth RN, Bromberg JS.

Nat Rev Nephrol. 2013 Apr;9(4):189-90. doi: 10.1038/nrneph.2013.37. Epub 2013 Mar 5. No abstract available.

PMID:
23458927
13.

Belatacept: a novel immunosuppressive agent for kidney transplant recipients.

Charpentier B.

Expert Rev Clin Immunol. 2012 Nov;8(8):719-28. doi: 10.1586/eci.12.79.

PMID:
23167683
14.

Costimulation blockade: current perspectives and implications for therapy.

Kinnear G, Jones ND, Wood KJ.

Transplantation. 2013 Feb 27;95(4):527-35. doi: 10.1097/TP.0b013e31826d4672. Review.

15.

Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection.

Ippoliti G, D'Armini AM, Lucioni M, Marjieh M, ViganĂ² M.

Biologics. 2012;6:355-62. doi: 10.2147/BTT.S27565. Epub 2012 Oct 4.

16.

Belatacept in kidney transplantation.

Wojciechowski D, Vincenti F.

Curr Opin Organ Transplant. 2012 Dec;17(6):640-7. doi: 10.1097/MOT.0b013e32835a4c0d. Review.

PMID:
23044530
17.

Affinity and cross-reactivity engineering of CTLA4-Ig to modulate T cell costimulation.

Xu Z, Juan V, Ivanov A, Ma Z, Polakoff D, Powers DB, Dubridge RB, Wilson K, Akamatsu Y.

J Immunol. 2012 Nov 1;189(9):4470-7. doi: 10.4049/jimmunol.1201813. Epub 2012 Sep 26.

18.

Belatacept: a new era of immunosuppression?

El-Charabaty E, Geara AS, Ting C, El-Sayegh S, Azzi J.

Expert Rev Clin Immunol. 2012 Aug;8(6):527-36. Review.

PMID:
22992146
19.

Modulating T-cell costimulation as new immunosuppressive concept in organ transplantation.

Pilat N, Schwarz C, Wekerle T.

Curr Opin Organ Transplant. 2012 Aug;17(4):368-75. doi: 10.1097/MOT.0b013e328355fc94. Review.

PMID:
22790071
20.

The inhibitor of costimulation of T cells: abatacept.

Iannone F, Lapadula G.

J Rheumatol Suppl. 2012 Jul;89:100-2. doi: 10.3899/jrheum.120257. Review.

PMID:
22751606
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk